Brand Introduction
If you're building your own practice or working independently, Botulax gives you access to the same botulinum toxin trusted by clinics across 70+ countries — without needing a hospital-scale supply contract to get it.
Botulax is developed by Hugel Inc., a South Korean biopharmaceutical company founded in 2001. It's Korea's top-selling botulinum toxin, and in the U.S. it's sold under the name Letybo, having earned FDA approval in 2023 — making Hugel the only South Korean company approved across the U.S., China, and Europe, the three biggest botulinum toxin markets in the world. That's the kind of regulatory track record you want backing a product you're putting your name behind with your own clients.
Products
Three vial sizes, so you're not overbuying or underbuying for your caseload:
Botulax 50: Smaller treatment areas, lighter caseloads, or when you want to titrate conservatively
Botulax 100: Your everyday workhorse — covers standard areas like glabellar lines, crow's feet, forehead lines
Botulax 200: Larger muscle groups or when you're seeing higher patient volume and want fewer reorders
You can start with a smaller vial size while you build your client base, then scale up as your practice grows.
Product Specifications
Active ingredient: Clostridium botulinum toxin type A, with human serum albumin and sodium chloride
Form: Freeze-dried powder, reconstituted with saline right before use
Available strengths: 50U, 100U, 200U
How it works: Temporarily blocks acetylcholine release at the neuromuscular junction, relaxing the treated muscle
Potency: Contains 844 units of neurotoxin protein per 100U vial — a higher protein content than some competing formulations, worth knowing when you're dosing
Onset: Patients typically start seeing results within about 3 days
Storage: Standard cold-chain handling as a freeze-dried product; check the product insert for your region's exact temperature guidance
Indications (region-dependent): eyelid spasm, crow's feet, glabellar lines, upper extremity spasticity post-stroke, cerebral palsy adduction deformity in children.
FAQs
Is this the same as Botox?
No — different manufacturer, different formulation. Botulax has shown greater potency per unit than Botox in some studies, which is worth factoring into how you dose if you're used to working with a different brand.
Botulax vs. Letybo — is there a difference?
Same product. Letybo is just the name it's sold under in the U.S. after FDA approval.
How fast will my clients see results?
Around 3 days for initial effect, building over the next week or two to full result.
What areas can I treat with it?
Its molecular weight and albumin profile keep it fairly contained at the injection site, which makes it a solid choice for larger areas like the masseter or calf, on top of the usual facial treatment zones.
Do I need a license to order this?
Yes. This is a prescription-only injectable — it's meant for licensed, trained medical or aesthetic professionals to administer. It's not sold for self-use.
What size vial should I start with as a solo practitioner?
If you're just getting your caseload going, 50U or 100U keeps you flexible without a big upfront commitment. Move to 200U once your volume justifies it.
Related Products
Good pairings for your storefront or reorder suggestions:
Revolax — Hugel's own HA dermal filler line, a natural add-on if you're already offering combination toxin + filler treatments
Any HA fillers already in your catalog, for cross-sell into full-face treatment plans
Reconstitution supplies (saline, syringes) if you stock consumables
A simple aftercare guide or client handout — nice touch for independent providers building their own client trust
Professional Information
Regulatory status: Prescription-only; you'll need to verify your licensing to purchase
Who it's for: Licensed physicians, dermatologists, nurse injectors, and certified aesthetic practitioners working independently
Clinical backing: Phase 3 trials on 1,200+ patients with glabellar wrinkles (randomized, double-blind, placebo-controlled) showed 94% improvement at 4 weeks, maintained for 4 months
Global approvals: FDA (as Letybo, 2023), Europe, China, and UAE (2025, covering both aesthetic and therapeutic use)
Manufacturer: Hugel Inc., a publicly listed, established biopharmaceutical company
